However, the aforementioned negative correlation between PRAME expression and PD‐L1 expression suggests that treatment with PD‐L1/PD‐1 inhibitors may be less beneficial in PRAME overexpressing tumours as a result of reduced target PD‐L1 expression. This evidence concerns the gene CD274 and neoplasm.